Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Kilitch Drugs (India) Ltd

KILITCH.NS ✓ COMPLIANT ☆ Track — members

NSE India · Healthcare · Pharmaceuticals ·

India Micro Cap Analyst: N/A

Last Close

$1.90

▼ -5.00%

Market Cap $66.55M · Vol 7.23K

Key Metrics

P/E Ratio

20.62

FWD: 24.22

Market Cap

$66.55M

Micro Cap

Div Yield

N/A

Annual dividend

EPS Growth

N/A

YoY

RSI (14)

51.20

Momentum

Beta

1.50

vs Market

52W High

$2.30

23.51% below

52W Low

$1.23

53.17% above

Volume

7.23K

Avg 23.40K

P/B

1.56

Price-to-book

ROE

N/A

Return on equity

Free Float

28.24%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Kilitch Drugs (India) Ltd (KILITCH.NS) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does KILITCH.NS pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-6.13%

+3.60%

+17.15%

+11.12%

YTD

+3.75%

-14.60%

+70.69%

+86.99%

Financials & Valuation

TTM · Annual

Total Revenue	$25.20M
Net Income	$3.16M
Revenue Growth (YoY)	+4.03%
Gross Margin	35.81%
Operating Margin	14.00%
Net Profit Margin	12.53%
ROE	N/A
ROA · ROIC	10.03% · 11.18%

P/E Ratio	20.62
Forward P/E (FY1)	24.22
PEG Ratio	1.44
P/S	1.79
P/B	1.56
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	34.96M

Technical Indicators

50-Day SMA	$1.95
200-Day SMA	$1.79
RSI (14)	51.20
Beta	1.50
52-Week High	$2.30
52-Week Low	$1.23

Volume Today	7.23K
Avg Daily Volume (30D)	23.40K
Relative Volume	0.31x
Volatility (10D)	28.45
Volatility (30D)	31.61
Free Float	28.24%

Analyst Consensus

N/A

Current Price $1.90

Mean Target $2.63

52W Low$1.23 52W High$2.30

Current

Target

$1.23 $2.30

Current Analyst target

+38.28% upside potential · 0 analysts

Identifiers

ExchangeNSE India

FIGIBBG001S85L43

ISININE729D01010

CountryIndia

Sub-IndustryPharmaceuticals (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeFULLPAID Fully Paid Ordinary

Similar Halal Stocks

LLY Eli Lilly and Co -2.39% JNJ Johnson & Johnson -0.66% ABBV Abbvie Inc -0.54% NVS Novartis AG -0.55% NOVN.S Novartis AG -1.05%

Company Profile

Kilitch Drugs (India) Limited is an India-based pharmaceutical manufacturing company. The Company is mainly engaged in the development and operations of the pharmaceutical business. Its services range from manufacturing to marketing a host of formulations in all dosage forms. The Company offers products in the categories of Parenteral and Nasal Products, Oral, Effervescent, Nutritional Products, Medical Devices, and Cosmetics and Herbal Products. It offers products that help in gastroenterology, anti-inflammatory, anti-malaria, diagnostics, uterine stimulants, veterinary and many more areas in the form of ampoules & vials. Its range of oral formulations includes tablets, capsules, dry syrups and oral powders. It provides a range of cosmetics ranging from oil, lotion, liquid to cream and paste in the skin care, personal care and hair care categories. It offers a medical device, namely, the C-Seal. ROIPAR, ROIVIT, PH-7, C-SEAL, SRO-KIT, 9-VIT, HPURE are their product offerings.